Despite Successes, Addiction Treatment Programs for Families Struggle to Stay Open
Discusses the challenges that come with providing family-based residential treatment for addiction in rural Minnesota. Notes that treatment in a family-based facility can improve pregnancy outcomes, increase chances of completing treatment, and keep families from being separated. Maternal opioid-related diagnoses have increased in recent years with a disproportionate rise seen in rural areas.
Source: News stories via the Rural Assistance Center - September 13, 2023 Category: Rural Health Source Type: news

Legal Actions Seek Guarantee of Abortion Access for Patients in Medical Emergencies
Patients in three states — Idaho, Tennessee and Oklahoma — filed lawsuits claiming that their abortion bans prevented women with serious pregnancy complications from receiving treatment. New cases say fear and confusion about abortion bans in three states are causing doctors and hospitals to deny…#idaho #tennessee #oklahoma #jacistatton #supremecourt #stateoftexas #missouri #kansas #laboract #emtala
Source: Reuters: Health - September 12, 2023 Category: Consumer Health News Source Type: news

Scottsdale pharmaceutical firm secures $19M exclusive license fee
A Scottsdale pharmaceutical company just secured a licensing agreement to expand one of its products in Asia. The cash infusion comes at a time when the company is preparing to submit an application to the FDA for a new treatment it is developing for a severe skin condition.
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 12, 2023 Category: Pharmaceuticals Authors: Angela Gonzales Source Type: news

Company Submits Supplemental NDA for Topical AD Treatment Company Submits Supplemental NDA for Topical AD Treatment
Submission is based on positive results from two phase 3, vehicle-controlled trials in patients ages 6 and older with mild to moderate AD.MDedge News
Source: Medscape Medical News Headlines - September 12, 2023 Category: Consumer Health News Tags: Dermatology News Source Type: news

Post-acute infection syndromes will be the focus of new YSM center
Yale ’s Center for Infection& Immunity will investigate long COVID, myalgic encephalomyelitis/chronic fatigue syndrome, and post-treatment Lyme disease.
Source: Yale Science and Health News - September 12, 2023 Category: Universities & Medical Training Source Type: news

Five-in-one CS 9600 CBCT System is a Five-time Cellerant Best of Class Technology Award Winner
 ATLANTA —Continual innovation and market-leading technology has earned Carestream Dental ’s CS 9600 CBCT system its fifth-straight Cellerant Best of Class Technology Award. The system combines advanced hardware with powerful software to make sure doctors are always practicing on the cutting edge. Available in three editions with 10, 12 and 14 fields of view (FOV)s, the CS 9600 is sized to meet doctors ’ needs so they can focus on the smallest detail of root morphology or zoom out to see the full picture, including the TMJ and sinuses. But the system doesn’t just capture high-quality images, it ...
Source: Dental Technology Blog - September 12, 2023 Category: Dentistry Source Type: news

Record number of Brits paying for medical treatment amid NHS backlog crisis
Around 227,000 people in the UK sought private treatment in the first three months of 2023. It marks a four per cent jump on the previous record of 219,000 set in the final quarter of 2022.
Source: the Mail online | Health - September 12, 2023 Category: Consumer Health News Source Type: news

Young campaigners call on Rishi Sunak to launch cancer travel fund
Charity Young Lives vs Cancer is urging the Government to help patients aged up to 25 and their families meet the cost of travelling to access treatment, often at specialist centres further away.
Source: Daily Express - Health - September 12, 2023 Category: Consumer Health News Source Type: news

Med Students Also Plagued by High Insurance Costs for Mental Health
(MedPage Today) -- Health insurance coverage for mental health treatment for medical students after the worst of the COVID-19 pandemic had a median out-of-network annual deductible at least twice the median in-network deductible, though most schools...
Source: MedPage Today Psychiatry - September 12, 2023 Category: Psychiatry Source Type: news

Too Many Mothers Are Dying in Childbirth. Here ’s How They Can Be Saved
With recent reports of difficult pregnancies and births from celebrities like Beyonce, Serena Williams, and Alyson Felix, and the death of Olympian Tori Bowie during childbirth, the long-overlooked dangers of maternal and child mortality have become increasingly prominent. In a new report published by the Bill & Melinda Gates Foundation, the global health philanthropic group highlights lagging progress in achieving United Nations (UN) goals for lowering mother and child deaths, along with innovative ways of addressing the problems with relatively inexpensive and easy to implement solutions that the group projects co...
Source: TIME: Health - September 12, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized healthscienceclimate Source Type: news

Few With CRC in Sub-Saharan Africa Receive Guideline-Concordant Care
TUESDAY, Sept. 12, 2023 -- Fewer than one in 20 patients diagnosed with colorectal cancer (CRC) in Sub-Saharan Africa (SSA) receive guideline-concordant treatment, according to a study published in the September issue of the Journal of the National...
Source: Drugs.com - Pharma News - September 12, 2023 Category: Pharmaceuticals Source Type: news

Woman, 45, given all-clear after NHS smear test is diagnosed with cervical cancer three years later - after blunder saw her given incorrect result
Shona Clark, from Northumberland, had a routine cervical screening test in 2015 that should have highlighted abnormal changes in the cells of her cervix and triggered further checks and treatment.
Source: the Mail online | Health - September 12, 2023 Category: Consumer Health News Source Type: news

Drug Trials Snapshot: WELIREG
WELIREG is a drug used for the treatment of adults with von Hippel-Lindau (VHL) disease.
Source: FDA Center for Drug Evaluation and Research - What's New - September 12, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Adding First-Line Chemo Boosts PFS in EGFR-Mutant Lung Cancer
(MedPage Today) -- SINGAPORE -- Treatment with osimertinib (Tagrisso) plus chemotherapy reduced the risk of disease progression or death by 38% compared with osimertinib monotherapy in patients with advanced EGFR-mutant non-small cell lung cancer...
Source: MedPage Today Hematology/Oncology - September 12, 2023 Category: Hematology Source Type: news

Pages: 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20